Anti-VEGF Agents in the Treatment of Neovascular Age-related Macular Degeneration: Applying Clinical Trial Results to the Treatment of Everyday Patients-Reference-Cited by-同舟云学术

Anti-VEGF Agents in the Treatment of Neovascular Age-related Macular Degeneration: Applying Clinical Trial Results to the Treatment of Everyday Patients

Published:2007-10 Issue:4 Volume:144 Page:627-637.e2
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Brown David M.,Regillo Carl D.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference35 articles.

1. Argon laser photocoagulation for senile macular degeneration;Arch Ophthalmol,1982

2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report;Arch Ophthalmol,1999

3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP Report no. 2;Bressler;Arch Ophthalmol,2001

4. Pegaptanib for neovascular age-related macular degeneration;Gragoudas;N Engl J Med,2004

5. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of long-term (34 years) observation of a patient with ophthalmological manifestations of Grenblad–Strandberg syndrome;Ophthalmology Reports;2024-07-09

2. Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice;Ophthalmology and Therapy;2024-07-08

3. Regulation of angiogenesis and inflammatory pathways by glycyrrhizic acid;Egyptian Journal of Dermatology and Venereology;2024-04-18

4. Clinical Outcomes of Retinal Arterial Macroaneurysms With Vitreous Hemorrhage Treated With Observation, Antivascular Endothelial Growth Factor Intravitreal Injections, or Pars Plana Vitrectomy;Journal of VitreoRetinal Diseases;2023-10-03

5. Vitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage;Life Science Alliance;2023-05-09